MORGAN STANLEY

Holdings History for ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Symbol: SPRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$6,435,049	552,364	-148,050	-21%	$11.65	Q4 2025
30 Sep 2025	0%	+0%	$7,039,160	700,414	+316,798	+83%	$10.05	Q3 2025
30 Jun 2025	0%	-0%	$6,694,106	383,616	-58,898	-13%	$17.45	Q2 2025
31 Mar 2025	0%	+0%	$5,566,825	442,514	+9,911		$12.58	Q1 2025
31 Dec 2024	0%	-0%	$4,563,963	432,603	-206,019		$10.55	Q4 2024
30 Sep 2024	0%	+0%	$9,260,021	638,622	+504,816	+300%	$14.50	Q3 2024
30 Jun 2024	0%	+0%	$1,138,688	133,806	+35,853		$8.51	Q2 2024
31 Mar 2024	0%	-0%	$1,001,080	97,953	-9,960	-9.2%	$10.22	Q1 2024
31 Dec 2023	0%	+0%	$591,364	107,913	+23,700	+28%	$5.48	Q4 2023
30 Sep 2023	0%	+0%	$318,326	84,213	+23,534	+39%	$3.78	Q3 2023
30 Jun 2023	0%	-0%	$406,549	60,679	-38,927	-39%	$6.70	Q2 2023
31 Mar 2023	0%	+0%	$648,436	99,606	+10,392	+12%	$6.51	Q1 2023
31 Dec 2022	0%	+0%	$760,996	89,214	+33,149	+59%	$8.53	Q4 2022
30 Sep 2022	0%	-0%	$295,000	56,065	-181,542	-76%	$5.26	Q3 2022
30 Jun 2022	0%	-0%	$1,008,000	237,607	-148,340	-38%	$4.24	Q2 2022
31 Mar 2022	0%	-0%	$1,355,000	385,947	-1,004,942	-72%	$3.51	Q1 2022
31 Dec 2021	0%	+0%	$9,263,000	1,390,889	+752,275	+118%	$6.66	Q4 2021
30 Sep 2021	0%	+0%	$6,374,000	638,614	+625,390	+4729%	$9.98	Q3 2021
30 Jun 2021	0%	+0%	$408,000	13,224	+13,224	NEW	$30.85	Q2 2021
31 Mar 2021		-0%	$0	0	-2,365	-100%	$8.81	Q1 2021
31 Dec 2020	0%	+0%	$110,000	2,365	+2,365	NEW	$46.51	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.